Literature DB >> 28073910

Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques.

Tom F Brouwer1, Marc A Miller2, Anne-Floor B E Quast2, Chandrasekar Palaniswamy2, Srinivas R Dukkipati2, Vivek Reddy2, Arthur A Wilde2, Jonathan M Willner2, Reinoud E Knops2.   

Abstract

BACKGROUND: Alternative techniques to the traditional 3-incision subcutaneous implantation of the subcutaneous implantable cardioverter-defibrillator may offer procedural and cosmetic advantages. We evaluate 4 different implant techniques of the subcutaneous implantable cardioverter-defibrillator. METHODS AND
RESULTS: Patients implanted with subcutaneous implantable cardioverter-defibrillators from 2 hospitals between 2009 and 2016 were included. Four implantation techniques were used depending on physician preference and patient characteristics. The 2- and 3-incision techniques both place the pulse generator subcutaneously, but the 2-incision technique omits the superior parasternal incision for lead positioning. Submuscular implantation places the pulse generator underneath the serratus anterior muscle and subfascial implantation underneath the fascial layer on the anterior side of the serratus anterior muscle. Reported outcomes include perioperative parameters, defibrillation testing, and clinical follow-up. A total of 246 patients were included with a median age of 47 years and 37% female. Fifty-four patients were implanted with the 3-incision technique, 118 with the 2-incision technique, 38 with submuscular, and 37 with subfascial. Defibrillation test efficacy and shock lead impedance during testing did not differ among the groups; respectively, P=0.46 and P=0.18. The 2-incision technique resulted in the shortest procedure duration and time-to-hospital discharge compared with the other techniques (P<0.001). A total of 18 complications occurred, but there were no significant differences between the groups (P=0.21). All infections occurred in subcutaneous implants (3-incision, n=3; 2-incision, n=4). In the 2-incision group, there were no lead displacements.
CONCLUSIONS: The presented implantation techniques are feasible alternatives to the standard 3-incision subcutaneous implantation, and the 2-incision technique resulted in shortest procedure duration.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  implantable cardioverter-defibrillator; implantation; implantation technique; subcutaneous implantable cardioverter-defibrillator; ventricular arrhythmia

Mesh:

Year:  2017        PMID: 28073910     DOI: 10.1161/CIRCEP.116.004663

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  6 in total

Review 1.  Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.

Authors:  Khi Yung Fong; Colin Jun Rong Ng; Yue Wang; Colin Yeo; Vern Hsen Tan
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

2.  Streamlined Surgical Draping Reduces Subcutaneous Implantable Cardioverter-defibrillator Implant Procedure Preparation Time.

Authors:  Marcy Mcqueen; Lori A Woodford; Eric Holick; Kevin Wolfer; Anish K Amin
Journal:  J Innov Card Rhythm Manag       Date:  2018-07-15

3.  Undetected displacement of a subcutaneous implantable cardioverter-defibrillator lead. importance of performing a chest X-ray during the first weeks post-implant: a case report.

Authors:  Jose Apolo; Rodolfo San Antonio; Lluís Mont; José María Tolosana
Journal:  Eur Heart J Case Rep       Date:  2019-10-22

Review 4.  Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infections.

Authors:  Raul Weiss; George E Mark; Mikhael F El-Chami; Mauro Biffi; Vincent Probst; Pier D Lambiase; Marc A Miller; Timothy McClernon; Linda K Hansen; Bradley P Knight; Larry M Baddour
Journal:  J Cardiovasc Electrophysiol       Date:  2022-06-09       Impact factor: 2.942

5.  Is shock impedance value alone to be considered a good predictor for shock efficacy in subcutaneous implantable cardioverter defibrillator?

Authors:  Enrico Di Girolamo; Nanda Furia; Massimiliano Faustino; Marianna Appignani; Giampiero Arcari; Alessandro Angelini; Loris Spadoni
Journal:  Clin Case Rep       Date:  2018-02-07

6.  Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland.

Authors:  Krzysztof Kaczmarek; Maciej Kempa; Marcin Grabowski; Mateusz Tajstra; Adam Sokal; Iwona Cygankiewicz; Radosław Zwoliński; Marcin Michalak; Michal Kowara; Szymon Budrejko; Anna Kurek; Jerzy K Wranicz; Grzegorz Raczak; Grzegorz Opolski; Mariusz Gąsior; Oskar Kowalski; Paweł Ptaszyński
Journal:  Arch Med Sci       Date:  2019-05-21       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.